Glenda Halliday
Halliday, Glenda M.
VIAF ID: 107351351 (Personal)
Permalink: http://viaf.org/viaf/107351351
Preferred Forms
-
100 0 _ ‡a Glenda Halliday
-
100 1 _ ‡a Halliday, Glenda M.
-
100 1 _ ‡a Halliday, Glenda M.
-
-
100 1 _ ‡a Halliday, Glenda M.
-
100 1 _ ‡a Halliday, Glenda M.
4xx's: Alternate Name Forms (5)
5xx's: Related Names (2)
- 551 _ _
‡a
Sydney
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _
‡a
University of New South Wales
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
Title | Sources |
---|---|
Atlas of the developing mouse brain : at E17.5, PO, and P6 |
![]() |
Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients. |
![]() |
Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects |
![]() |
Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders |
![]() |
Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer? |
![]() |
Molecular Pathogenesis of the Tauopathies |
![]() |
Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. |
![]() |
Motor cortical function determines prognosis in sporadic ALS. |
![]() |
Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology |
![]() |
Movement disorder society criteria for clinically established early Parkinson's disease |
![]() |
Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia |
![]() |
Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG). |
![]() |
Mutations in progranulin explain atypical phenotypes with variants in MAPT. |
![]() |
Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS. |
![]() |
Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. |
![]() |
Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology. |
![]() |
Neurofibrillary tangles in chronic alcoholics. |
![]() |
Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies. |
![]() |
Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation |
![]() |
Neuronal intranuclear inclusion disease is genetically heterogeneous |
![]() |
Neuronal network disintegration: common pathways linking neurodegenerative diseases |
![]() |
Neuropathologic correlates of white matter hyperintensities |
![]() |
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria |
![]() |
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. |
![]() |
Neuropathology of three clinical cases prospectively diagnosed as dementia with Lewy bodies. |
![]() |
Neuropathology underlying clinical variability in patients with synucleinopathies |
![]() |
New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications |
![]() |
No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism. |
![]() |
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations |
![]() |
Non-dopamine lesions in Parkinson's disease, 2011: |
![]() ![]() ![]() ![]() |
Noradrenergic locus coeruleus neurons. |
![]() |
Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. |
![]() |
Organization of Human Brain Stem Nuclei |
![]() |
Overview and recent advances in neuropathology. Part 2: Neurodegeneration |
![]() |
P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy. |
![]() |
p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy |
![]() |
Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy |
![]() |
Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases |
![]() |
Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis |
![]() |
Parkinson's Disease Is Not Simply a Prion Disorder |
![]() |
Parkinson's disease with late Pick's dementia. |
![]() |
Parkinson's progression prediction using machine learning and serum cytokines |
![]() |
Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation. |
![]() |
Parvalbumin as an anatomical marker for discrete subregions of the ambiguus complex in the rat |
![]() |
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy |
![]() |
Pathologically proven frontotemporal dementia presenting with severe amnesia |
![]() |
Pathology and hippocampal atrophy in Alzheimer's disease. |
![]() |
Pathway analysis of the human brain transcriptome in disease |
![]() |
Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss |
![]() |
Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. |
![]() |
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. |
![]() |
Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. |
![]() |
Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains. |
![]() |
Physiological changes in neurodegeneration - mechanistic insights and clinical utility. |
![]() |
Pigmentation in the human brain and risk of Parkinson's disease. |
![]() |
Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques |
![]() |
Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease |
![]() |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. |
![]() |
Practical considerations for the use of the optical disector in estimating neuronal number. |
![]() |
Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia. |
![]() |
Preliminary evidence suggesting delayed development in the hypoglossal and vagal nuclei of SIDS infants: a necropsy study |
![]() |
Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy. |
![]() |
Preserved cognition and functional independence after a large right posterior cerebral artery infarct: longitudinal clinical and neuropathological findings. |
![]() |
Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. |
![]() |
Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy |
![]() |
Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy |
![]() |
Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. |
![]() |
Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata |
![]() |
Progressive supranuclear palsy finally has a clinically measureable τ abnormality |
![]() |
Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. |
![]() |
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease |
![]() |
Psychiatric disorders in kindreds: Study of 1,414 family members |
![]() |
Pyramidal cell loss in motor cortices in Huntington's disease |
![]() |
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay |
![]() |
Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. |
![]() |
Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human |
![]() |